SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001144204-18-002348
Filing Date
2018-01-17
Accepted
2018-01-17 09:19:49
Documents
1
Group Members
DAK CAPITAL INC.DAK INVESTMENTS CORP.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G (AMENDMENT NO. 3) tv483432_sc13ga.htm SC 13G/A 64024
  Complete submission text file 0001144204-18-002348.txt   65452
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
Fortress Biotech, Inc. (Subject) CIK: 0001429260 (see all company filings)

IRS No.: 205157386 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86661 | Film No.: 18530272
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1702 BELL TOWER, 10104-103 AVENUE EDMONTON Z4 T5J 0H8
Business Address
KATZ DARYL (Filed by) CIK: 0001625637 (see all company filings)

Type: SC 13G/A